81 related articles for article (PubMed ID: 17899084)
1. Further mechanistic unravelling of the influence of the cell cycle effects on the radiosensitising mechanism of vinflunine, in vitro.
Simoens C; Pauwels B; Vermorken JB; Pattyn GG; Lambrechts HA; Breillout F; Lardon F
Cancer Chemother Pharmacol; 2008 Jul; 62(2):183-93. PubMed ID: 17899084
[TBL] [Abstract][Full Text] [Related]
2. Cell cycle effects of vinflunine, the most recent promising Vinca alkaloid, and its interaction with radiation, in vitro.
Simoens C; Vermorken JB; Korst AE; Pauwels B; De Pooter CM; Pattyn GG; Lambrechts HA; Breillout F; Lardon F
Cancer Chemother Pharmacol; 2006 Aug; 58(2):210-8. PubMed ID: 16317558
[TBL] [Abstract][Full Text] [Related]
3. The radiosensitising effect of difluorodeoxyuridine, a metabolite of gemcitabine, in vitro.
Pauwels B; Korst AE; Lambrechts HA; Pattyn GG; de Pooter CM; Lardon F; Vermorken JB
Cancer Chemother Pharmacol; 2006 Aug; 58(2):219-28. PubMed ID: 16331496
[TBL] [Abstract][Full Text] [Related]
4. Exploring the mechanisms of action of the novel microtubule inhibitor vinflunine.
Jordan MA; Horwitz SB; Lobert S; Correia JJ
Semin Oncol; 2008 Jun; 35(3 Suppl 3):S6-S12. PubMed ID: 18538179
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of the radiosensitizing and cell cycle effects of vinflunine and vinorelbine, in vitro.
Simoens C; Lardon F; Pauwels B; De Pooter CM; Lambrechts HA; Pattyn GG; Breillout F; Vermorken JB
BMC Cancer; 2008 Feb; 8():65. PubMed ID: 18312675
[TBL] [Abstract][Full Text] [Related]
6. Vinflunine, a novel microtubule inhibitor, suppresses calmodulin interaction with the microtubule-associated protein STOP.
Makarov AA; Tsvetkov PO; Villard C; Esquieu D; Pourroy B; Fahy J; Braguer D; Peyrot V; Lafitte D
Biochemistry; 2007 Dec; 46(51):14899-906. PubMed ID: 18052208
[TBL] [Abstract][Full Text] [Related]
7. Vinflunine, a new vinca alkaloid: cytotoxicity, cellular accumulation and action on the interphasic and mitotic microtubule cytoskeleton of PtK2 cells.
Jean-Decoster C; Brichese L; Barret JM; Tollon Y; Kruczynski A; Hill BT; Wright M
Anticancer Drugs; 1999 Jul; 10(6):537-43. PubMed ID: 10885901
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics, metabolites, and preclinical safety of vinflunine.
Lobert S; Puozzo C
Semin Oncol; 2008 Jun; 35(3 Suppl 3):S28-33. PubMed ID: 18538176
[TBL] [Abstract][Full Text] [Related]
9. Novel actions of the antitumor drugs vinflunine and vinorelbine on microtubules.
Ngan VK; Bellman K; Panda D; Hill BT; Jordan MA; Wilson L
Cancer Res; 2000 Sep; 60(18):5045-51. PubMed ID: 11016627
[TBL] [Abstract][Full Text] [Related]
10. Head and neck carcinoma cell lines are sensitive to vinflunine in vitro.
Erjala K; Raitanen M; Kulmala J; Grénman R
Anticancer Res; 2005; 25(6B):4363-7. PubMed ID: 16309241
[TBL] [Abstract][Full Text] [Related]
11. Dichloroacetate (DCA) sensitizes both wild-type and over expressing Bcl-2 prostate cancer cells in vitro to radiation.
Cao W; Yacoub S; Shiverick KT; Namiki K; Sakai Y; Porvasnik S; Urbanek C; Rosser CJ
Prostate; 2008 Aug; 68(11):1223-31. PubMed ID: 18465755
[TBL] [Abstract][Full Text] [Related]
12. Vinflunine: review of a new vinca alkaloid and its potential role in oncology.
Ng JS
J Oncol Pharm Pract; 2011 Sep; 17(3):209-24. PubMed ID: 20584744
[TBL] [Abstract][Full Text] [Related]
13. Clinical activity of vinflunine in transitional cell carcinoma of the urothelium and other solid tumors.
Bellmunt J; Delgado FM; George C
Semin Oncol; 2008 Jun; 35(3 Suppl 3):S34-43. PubMed ID: 18538178
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of vinflunine: effector pathways and potential for synergies.
Braguer D; Barret JM; McDaid H; Kruczynski A
Semin Oncol; 2008 Jun; 35(3 Suppl 3):S13-21. PubMed ID: 18538174
[TBL] [Abstract][Full Text] [Related]
15. In vitro interaction between ecteinascidin 743 (ET-743) and radiation, in relation to its cell cycle effects.
Simoens C; Korst AE; De Pooter CM; Lambrechts HA; Pattyn GG; Faircloth GT; Lardon F; Vermorken JB
Br J Cancer; 2003 Dec; 89(12):2305-11. PubMed ID: 14676811
[TBL] [Abstract][Full Text] [Related]
16. Vinflunine: a new microtubule inhibitor agent.
Bennouna J; Delord JP; Campone M; Nguyen L
Clin Cancer Res; 2008 Mar; 14(6):1625-32. PubMed ID: 18347163
[TBL] [Abstract][Full Text] [Related]
17. Sensitization of the apoptotic effect of gamma-irradiation in genistein-pretreated CaSki cervical cancer cells.
Shin JI; Shim JH; Kim KH; Choi HS; Kim JW; Lee HG; Kim BY; Park SN; Park OJ; Yoon DY
J Microbiol Biotechnol; 2008 Mar; 18(3):523-31. PubMed ID: 18388472
[TBL] [Abstract][Full Text] [Related]
18. Flavopiridol potentiates the cytotoxic effects of radiation in radioresistant tumor cells in which p53 is mutated or Bcl-2 is overexpressed.
Hara T; Omura-Minamisawa M; Kang Y; Cheng C; Inoue T
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1485-95. PubMed ID: 18640498
[TBL] [Abstract][Full Text] [Related]
19. A comparison of thermodynamic parameters for vinorelbine- and vinflunine-induced tubulin self-association by sedimentation velocity.
Lobert S; Ingram JW; Hill BT; Correia JJ
Mol Pharmacol; 1998 May; 53(5):908-15. PubMed ID: 9584218
[TBL] [Abstract][Full Text] [Related]
20. Potential mechanisms of resistance to microtubule inhibitors.
Kavallaris M; Annereau JP; Barret JM
Semin Oncol; 2008 Jun; 35(3 Suppl 3):S22-7. PubMed ID: 18538175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
